Company Wound Management Technologies Inc Other OTC
Equities
US98211X1063
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Soft Tissue Repair Products
84.4
%
| - | - | 55 | 84.4 % | - |
Bone Fusion Products
15.3
%
| - | - | 10 | 15.3 % | - |
Royalty
0.3
%
| 0 | 0.4 % | 0 | 0.3 % | -.--% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 46 | 100.0 % | 65 | 100.0 % | +41.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael McNeil
DFI | Director of Finance/CFO | 59 | 18-04-10 |
Chief Tech/Sci/R&D Officer | - | 22-12-31 | |
Chief Tech/Sci/R&D Officer | 39 | 21-06-30 | |
Susan Dieter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bill Fitzgerald
CMP | Compliance Officer | - | - |
Callon Nichols
IRC | Investor Relations Contact | - | 19-07-31 |
Seth Yon
PRN | Corporate Officer/Principal | - | 17-12-31 |
Tricia Matteson
SAM | Sales & Marketing | - | - |
Carla Day
SAM | Sales & Marketing | - | - |
W. David Lee
PRN | Corporate Officer/Principal | - | 22-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Tanzberger
BRD | Director/Board Member | 55 | 21-12-31 |
Roszell Mack
BRD | Director/Board Member | 57 | 21-12-31 |
Eric Major
BRD | Director/Board Member | 55 | 23-05-31 |
James Stuckert
BRD | Director/Board Member | 86 | 15-09-20 |
Robert Desutter
BRD | Director/Board Member | 55 | 20-10-11 |
Ron Nixon
CEO | Chief Executive Officer | 68 | 19-03-14 |
Sara Ortwein
BRD | Director/Board Member | 65 | 20-12-17 |
Ann Salamone
BRD | Director/Board Member | 73 | 19-08-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,625,201 | 3,443,359 ( 39.92 %) | 0 | 39.92 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |